Wednesday, June 28, 2017 |
|
|
6:30 AM–7:30 AM |
Society for Birth Defects Research and Prevention 36TH ANNUAL VOLLEYBALL GAME – Benedict Fountain Park |
|
|
7:30 AM–8:30 AM |
BDR EDITORIAL BOARD MEETING - Mt. Wilson |
|
|
7:30 AM–8:30 AM |
EDUCATION COMMITTEE MEETING – Mt. Princeton |
|
|
7:30 AM–8:30 AM |
NOMINATION AND ELECTIONS COMMITTEE MEETING – Mt. Yale |
|
|
7:30 AM–2:30 PM |
REGISTRATION OPEN – Aspen Foyer |
|
|
7:30 AM–2:30 PM |
SPEAKER READY ROOM OPEN – Crestone Peak |
|
|
8:00 AM–8:30 AM |
MORNING COFFEE AND PASTRIES – Aspen Foyer
(Joint with DNTS) |
|
|
8:30 AM–9:30 AM |
Society for Birth Defects Research and Prevention AND EUROPEAN Society for Birth Defects Research and Prevention EXCHANGE LECTURE – Aspen Ballroom |
|
Morphological Variations in Animal Studies: Useful for Human Risk Assessment or a Red Herring? (L4) |
|
Chairpersons: Susan L. Makris, US Environmental Protection Agency and Manon Beekhuijzen, Charles River |
|
European Society for Birth Defects Research and Prevention
Paul C. Barrow, F. Hoffmann-La Roche Ltd. |
|
Society for Birth Defects Research and Prevention
Christopher J. Bowman, Pfizer Inc. |
|
|
9:35 AM–12:30 PM |
AN UPDATE ON THE ZIKA VIRUS SYMPOSIUM – Aspen Ballroom
(Joint with DNTS) |
|
Chairpersons: José F. Cordero, University of Georgia and Sonja A. Rasmussen, Centers for Disease Control and Prevention |
|
|
|
9:35 AM–9:50 AM |
|
Introduction |
|
|
Chairpersons: José F. Cordero, University of Georgia and
Sonja A. Rasmussen, Centers for Disease Control and Prevention |
|
|
|
9:50 AM–10:25 AM |
S47 |
The Zika Epidemic: An Update from the CDC |
|
|
Margaret Honein, Centers for Disease Control and Prevention |
|
|
|
10:25 AM–11:00 AM |
S48 |
Neurobehavioral Aspects of Zika Virus |
|
|
Vanessa Van den Linden, Assistance Association for Disabled Children |
|
|
|
11:00 AM–11:30 AM |
|
Warkany Tea |
|
|
|
11:30 AM–12:05 PM |
S49 |
Zika Infection: From Basic Science to Treatment |
|
|
Alysson Renato Muotri, University of California-San Diego |
|
|
|
12:05 PM–12:30 PM |
|
Panel Discussion |
|
|
|
11:00 AM–11:30 AM |
WARKANY TEA – Aspen Foyer
(Joint with DNTS) |
|
|
12:30 PM–1:30 PM |
AWARDS COMMITTEE MEETING - Mt. Yale |
|
|
12:30 PM–1:30 PM |
LUNCH ON YOUR OWN |
|
|
1:30 PM–4:30 PM |
FROM FRONT PAGE TO THE DIGITAL STAGE: HOW TO KEEP RESEARCH RELEVANT THROUGH MODERN MEDIA WORKSHOP (W5) – Colorado Ballroom A |
|
Chairperson: Christine Perdan Curran, Northern Kentucky University |
|
|
1:30 PM-1:50 PM |
Federation of American Societies for Experimental Biology's Approach to Science Policy Challenges: Getting Our Message Out |
|
Hudson Freeze, Federation of American Societies for Experimental Biology |
|
|
1:50 PM-2:10 PM |
Working Effectively with Science Journalists: From Deadline Reporting to In-Depth Coverage |
|
Elena Conis, University of California-Berkeley |
|
|
2:10 PM-2:30 PM |
News Versus Advocacy: Why Zika Is a Hot Story and Folic Acid Is Not |
|
Helen Branswell, STAT News |
|
|
2:30 PM-2:50 PM |
An Industry Perspective on Science Communication |
|
Donna R. Farmer, Monsanto Company |
|
|
2:50 PM-3:15 PM |
Effectively Using Images and Video in Scientific Communication |
|
Christine Perdan Curran, Northern Kentucky University |
|
|
3:15 PM-3:30 PM |
Break |
|
|
3:30 PM-4:30 PM |
Panel Discussion |
|
Moderator: Nicole Chavez, Communications Consultant |
|
|
|
1:30 PM–4:30 PM |
ILSI HESI WORKSHOP – Aspen Ballroom |
|
Redesigning the Embryofetal Developmental Toxicity Study: Evolution or Revolution? |
|
Chairpersons: George P. Daston, Procter & Gamble Company and Anthony R. Scialli, Scialli Consulting LLC |
|
|
|
1:30 PM–2:00 PM |
W6 |
Hypothesis-Driven Approaches for Assessing Developmental Toxicity |
|
|
George P. Daston, Procter & Gamble Company |
|
|
|
2:00 PM–2:30 PM |
W7 |
In Vitro Data and In Silico Models for Computational Toxicology |
|
|
Thomas B. Knudsen, National Center for Computational Toxicology, US EPA |
|
|
|
2:30 PM–3:15 PM |
W8 |
Redesigning the Embryofetal Developmental Toxicity Study: Revolution–Changing the Approach |
|
|
Aldert Piersma, RIVM |
|
|
|
3:15 PM–3:30 PM |
|
Break |
|
|
|
3:30 PM–3:45 PM |
W9 |
Improving Dose-Response Assessment in Developmental Toxicity Testing and Risk Assessment |
|
|
Sue Makris, US Environmental Protection Agency |
|
|
|
3:45 PM–4:00 PM |
W10 |
Humanized Experimental Models |
|
|
Alan Hoberman, Charles River Laboratories |
|
|
|
4:00 PM–4:15 PM |
W11 |
Models of Animal Disease |
|
|
Kary E. Thompson, Bristol-Myers Squibb and Pragati Sawhney Coder, Charles River Ashland |
|
|
|
4:15 PM–4:30 PM |
|
Discussion |
|
|
|
1:30 PM–4:30 PM |
PLATFORM SESSION 3 – Colorado Ballroom B |
|
Clinical Teratology |
|
Chairpersons: Jeffrey H. Charlap, Charles River Laboratories and Pragati Sawhney Coder, Charles River Ashland |
|
|
|
1:30 PM–1:45 PM |
|
Introduction |
|
|
|
1:45 PM–2:00 PM |
21 |
Fine Mapping for Genetic Susceptibility to Valproic Acid-Induced Exencephaly in Mice
Lei Y, Wlodarczyk BJ, Cabrera RM, Finnell RH. Dell Medical School, Austin, TX, United States. |
|
|
|
2:00 PM–2:15 PM |
22 |
In Utero Exposure to the Pesticide Synergist and Sonic Hedgehog Signaling Inhibitor Piperonyl Butoxide Causes Holoprosencephaly in Mice
Everson JL, Lipinski RJ. University of Wisconsin–Madison, Madison, WI, United States. |
|
|
|
2:15 PM–2:30 PM |
23 |
Gene-Environment Interactions in Holoprosencephaly
Muenke M1, Kruszka P1, Addissie Y1, Troia A2, Kozel B2, Everson J3, Malecki K4, Lipinski R3.
1National Human Genome Research Institute, NIH, Bethesda, MD, United States, 2National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States, 3Department of Comparative Biosciences, Molecular and Environmental Toxicology Center, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States, 4Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States. |
|
|
|
2:30 PM–2:45 PM |
24 |
Hypospadias, Intrauterine Growth Restriction, and Abnormalities of the Placenta
Toufaily MH1, Roberts D2, Westgate M-N1, Hunt A-T3, Holmes LB1. 1MassGeneral Hospital for Children, Boston, MA, United States, 2Massachusetts General Hospital, Boston, MA, United States, 3Hunt Consulting Associates, Chapel Hill, NC, United States. |
|
|
|
2:45 PM–3:00 PM |
25 |
Changes in Serum Lipid Profiles in Neonatal Monkeys Associated with Sevoflurane-Induced Neurotoxicity
Slikker W1, Wang C2, Han X2, Liu F1, Gu Q1, Liu S1, Patterson T1, Paule M1, Hanig J3, Wang C1. 1National Center for Toxicological Research, US FDA, Jefferson, AR, United States, 2Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona, Orlando, FL, United States, 3Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, United States. |
|
|
|
3:15 PM–3:30 PM |
26 |
Maternal Antihypertensive Medication Use and Selected Birth Defects in the National Birth Defects Prevention Study
Fisher SC1, Van Zutphen AR1,2, Werler MM3, Romitti PA4, Cunniff CM5. 1Congenital Malformations Registry, New York State Department of Health, Albany, NY, United States, 2Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, Rensselaer, NY, United States, 3Department of Epidemiology, School of Public Health, Boston University, Boston, MA, United States, 4Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, United States, 5Department of Pediatrics, Weill Cornell Medical College, New York, NY, United States. |
|
|
|
3:30 PM–3:45 PM |
27 |
A Mysterious Story of Embryo-Foetal Developmental Toxicity in Rats with AX
Zhuang Q, Rasmussen AD, Bernholm K, Northeved H. Nonclinical Safety Research, H. Lundbeck A/S, Copenhagen, Denmark. |
|
|
|
3:45 PM–4:00 PM |
28 |
Birth Outcomes following Pregnancy Exposure to Adalimumab: The OTIS Autoimmune Diseases in Pregnancy Project
Chambers CD1, Johnson DL1, Xu R1, Luo Y1, Adam MP2, Braddock SR3, Robinson L4, Vaux K1, Jones KL1, The OTIS Collaborative Research Group1. 1University of California–San Diego, La Jolla, CA, United States, 2University of Washington, Seattle, WA, United States, 3Saint Louis University, St. Louis, MO, United States, 4University at Buffalo, Buffalo, NY, United States. |
|
|
|
4:00 PM–4:15 PM |
29 |
Birth Defect Surveillance As a Requirement for Reducing Birth Defects in a Developing Country
Fakoya FA1, Wade A2. 1St. George's University II, Newcastle Upon Tyne, United Kingdom, 2St. George's University, St. George's, Grenada. |
|
|
|
4:15 PM–4:30 PM |
30 |
Clinical Variability of the Congenital Zika Syndrome
Del Campo M1, Feitosa IML2, Garcia-Alix A3, Schuler-Faccini L2. 1University of California–San Diego, San Diego, CA, United States, 2Universidade Federal de Rio Grande do Sul, Porto Alegre, RGDS, Brazil, 3Institut de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, Catalunya, Spain. |
|
|
|
4:30 PM–6:00 PM |
BUSINESS MEETING – Aspen Ballroom |
|
|
6:30 PM–7:30 PM |
BANQUET RECEPTION – Capitol Peak Ballroom Foyer |
|
|
7:30 PM–11:00 PM |
BANQUET – Capitol Peak Ballroom |
|
Travel Awards
James C. Bradford Memorial Student Poster Awards
Wilson Presentation Awards
Marie W. Taubeneck Award
Edward W. Carney Trainee Award
Birth Defects Research Distinguished Scholar Awards
Edward W. Carney Distinguished Service Award
Recognition of Other Awards Presented throughout the Week
|
|
|